NEW YORK Michael Pearson, the former chief executive officer of Valeant Pharmaceuticals International (VRX.TO), has signed a consulting agreement with the drugmaker that will run through 2017 and pay him hundreds of thousands of dollars, according to the separation agreement filed with regulators.
Pearson, who left Valeant on May 2 after a year in which it had drawn scrutiny for its sharp drug price increases, financial relationship with a specialty pharmacy and accounting practices, can earn $83,333 a month this year as a consultant.
20:27 The best hire Indiana could have made: Hoosiers opt for quality over nostalgia with Dayton's Archie Miller12
22:04 London, Donald Trump, Keystone Pipeline: Your Evening Briefing24
22:20 Overnight Regulation: Senate moves to strike Obama-era internet privacy rules24
18:48 Italy federation to honour Claudio Ranieri for work with Leicester13